Citation Impact
Citing Papers
microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma
2010
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
2009 Standout
MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
2010
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
2009
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
2012
Temporal requirements for ISL1 in sympathetic neuron proliferation, differentiation, and diversification
2018
Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs
2016 Standout
Chemosensitivity linked to p73 function
2003 StandoutNobel
FGFR3 mutations in prostate cancer: association with low-grade tumors
2009
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
2009
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
MYC on the Path to Cancer
2012 Standout
The FGF family: biology, pathophysiology and therapy
2009 Standout
Ulcerative Colitis
2011 Standout
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter
2006
A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans
2009
Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion
1994
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
1997 StandoutNobel
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
2017 Standout
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma
2011
The Cancer Genome Atlas Pan-Cancer analysis project
2013 Standout
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis
2011
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors
2010
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Treating ALK-positive lung cancer—early successes and future challenges
2012
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
2009
MicroRNA biogenesis pathways in cancer
2015 Standout
Bladder cancer
2016 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Recent Advances in Neuroblastoma
2010
Apoptosis
2002 Standout
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
2012
Mosaicism of activatingFGFR3 mutations in human skin causes epidermal nevi
2006
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Making sense of cancer genomic data
2011
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes.
1993
Portrait of PTEN: Messages from mutant mice
2008 StandoutNobel
Induction of gene encoding FABP4 in Pten‐null keratinocytes
2009 StandoutNobel
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
Advances in understanding cancer genomes through second-generation sequencing
2010
Clinical implications of p53 mutations
1999
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
2011
Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors
2012
A census of amplified and overexpressed human cancer genes
2009
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Anaplastic lymphoma kinase as a therapeutic target
2012
Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B–containing lipoproteins
2008 StandoutNobel
Crizotinib in the Treatment of Non–Small-Cell Lung Cancer
2013
Transcriptional Regulation of the Glucose-6-phosphatase Gene by cAMP/Vasoactive Intestinal Peptide in the Intestine
2006
Clonal evolution in cancer
2012 StandoutNature
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Role of Reactive Oxygen Species and p53 in Chromium(VI)-induced Apoptosis
1999 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Snail controls differentiation of hepatocytes by repressing HNF4α expression
2006
Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling
2012
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
Genetics of ulcerative colitis
2010
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Cancer genomics: from discovery science to personalized medicine
2011
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
ALK inhibitors in non-small cell lung cancer: crizotinib and beyond.
2014
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine
2015
Transcriptional Regulation of the Glucose-6-phosphatase Gene by cAMP/Vasoactive Intestinal Peptide in the Intestine
2006
Breast Cancer Treatment
2019 Standout
Uterine stem cells: from basic research to advanced cell therapies
2018
Inhibitors of the anaplastic lymphoma kinase
2012
Endometriosis
2020 Standout
Cancer Genome Landscapes
2013 StandoutScience
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
2006
Anaplastic lymphoma kinase: signalling in development and disease
2009
Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis
2001
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients
2012
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
1999
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922
2015
Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
2009
Works of Agnès Ribeiro being referenced
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
Cholinergic switch associated with morphological differentiation in neuroblastoma
2009
Characterization of amplicons in neuroblastoma: High‐resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes
2008
E-cadherin-dependent Transcriptional Control of Apolipoprotein A-IV Gene Expression in Intestinal Epithelial Cells
2005
Two Initiator-like Elements Are Required for the Combined Activation of the Human Apolipoprotein C-III Promoter by Upstream Stimulatory Factor and Hepatic Nuclear Factor-4
2002
Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
2014
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
2008 Nature
MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors
2012
Effect of dietary fish oil and corn oil on lipid metabolism and apolipoprotein gene expression by rat liver
1991
Restriction of Apolipoprotein A-IV Gene Expression to the Intestine Villus Depends on a Hormone-responsive Element and Parallels Differential Expression of the Hepatic Nuclear Factor 4α and γ Isoforms
2002
Cooperative Binding of Upstream Stimulatory Factor and Hepatic Nuclear Factor 4 Drives the Transcription of the Human Apolipoprotein A-II Gene
1999
Effect of simvastatin on the synthesis and secretion of lipoproteins in relation to the metabolism of cholesterol in cultured hepatocytes
1991
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans
2005
Relationship between radiation response and p53 status in human bladder cancer cells
1997
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
2009
Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
2010
Hepatocyte Nuclear Factor 4α, a Key Factor for Homeostasis, Cell Architecture, and Barrier Function of the Adult Intestinal Epithelium
2009